Institut für Labormedizin
Publikationen 2016
Originalartikel
Kutz A, Hausfater P, Oppert M, Alan M, Grolimund E, Gast C, Alonso C, Wissmann C, Kuehn C, Bernard M, Huber A, Mueller B, Schuetz P. Comparison between B·R·A·H·M·S PCT direct, a new sensitive point-of-care testing device for rapid quantifica- tion of procalcitonin in emergency department patients, and established reference meth- ods - a prospective multinational trial. Clinical Chemistry and Laboratory Medicine. 2016;
54(4): 577-584 (IF 2015: 3.017)
Steuer C, Schütz P, Bernasconi L, Huber AR. Simultaneous determination of phospha- tidylcholine-derived quaternary ammonium compounds by a LC-MS/MS method in hu- man blood plasma, serum and urine samples. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2016; 1008: 206-11 (IF 2015: 2.687)
Bernasconi L, Mundwiler E. Monoklonale Gammopathien: Neue IMWG-Kriterien und Labortests für die Diagnose, Prognose und Verlaufskontrolle des Multiplen Myeloms.
Pipette. 2016; 1: 11-13
Tobler A, Hösli R, Mühlebach S, Huber A. Free phenytoin assessment in patients:
measured versus calculated blood serum levels. International Journal of Clinical Phar- macy. 2016; 38(2): 303-9 (IF 2015: 1.129)
Pichler Hefti J, Leichtle A, Stutz M, Hefti U, Geiser T, Huber AR, Merz TM. Increased endothelial microparticles and oxidative stress at extreme altitude. European Journal of Applied Physiology. 2016; 116(4): 739-48 (IF 2015: 2.328)
Huber AR. Orphan Diseases – seltene Krankheiten. Psychiatrie & Neurologie. 2016; 3:
21-22
Huber A. Diagnose und Therapie des Eisenmangels im Alter. Schweizer Zeitschrift für Ernährungsmedizin. 2016; 3: 24-26
Röthlisberger B. Krebs in der Familie: wann zum Genetiker? Schweizer Zeitschrift für Onkologie. 2016; 1: 15-19
Felder S, Braun N, Stanga Z, Kulkarni P, Faessler L, Kutz A, Steiner D, Laukemann S, Haubitz S, Huber A, Mueller B, Schuetz P. Unraveling the Link between Malnutrition and Adverse Clinical Outcomes: Association of Acute and Chronic Malnutrition Measures with Blood Biomarkers from Different Pathophysiological States. Annals of Nutrition and Me- tabolism. 2016; 68(3): 164-72 (IF 2015: 2.461)
Steuer C, Huber AR. Sinnvolle Laboruntersuchungen bei chronischer Müdigkeit. Haus- arzt Praxis. 2016; 11 (4): 30-32
Huber A. Welches ist der Nutzen der Labormedizin? Pipette. 2016; 2: 6-7
Huber AR, Risch M. Nutzen der Labormedizin. Schweizerische Ärztezeitung. 2016;
97(18–19): 656–57
Ottiger C, Gygli N, Huber AR, Fernandez-Tresguerres B, Pardo S, Petruschke T. Per- formance of a Blood Glucose Monitoring System in a Point-of-Care Setting. Journal of Diabetes Science and Technology. 2016; 10(4):939-46
Lindert U, Cabral WA, Ausavarat S, Tongkobpetch S, Ludin K, Barnes AM, Yeetong P, Weis M, Krabichler B, Srichomthong C, Makareeva EN, Janecke AR, Leikin S, Röthlis- berger B, Rohrbach M, Kennerknecht I, Eyre DR, Suphapeetiporn K, Giunta C, Marini JC & Shotelersuk V. MBTPS2 mutations cause defective regulated intramembrane pro- teolysis in X-linked osteogenesis imperfecta. Nature Communications. 2016;
7:11920/DOI: 10.1038/ncomms119200 (IF 2015: 11.329)
Steuer C, Huber AR, Bernasconi L. Where clinical chemistry meets medicinal chemis- try. Systematic analysis of physico-chemical properties predicts stability of common used drugs in gel separator serum tubes. Clinica Chimica Acta. 2016; 462: 23-27 (IF 2015:
2.799)
Kaeslin MA, Killer HE, Fuhrer CA, Zeleny N, Huber AR, Neutzner A. Changes to the Aqueous Humor Proteome during Glaucoma. PLoS One. 2016; 11(10): e0165314. (IF 2015: 3.057)
Aeberhard C, Steuer C, Saxer C, Huber A, Stanga Z, Mühlebach S. Physicochemical stability and compatibility testing of levetiracetam in all-in-one parenteral nutrition admix- tures in daily practice. European Journal of Pharmaceutical Sciences. 2016; 96: 449-455 (IF 2015: 3.773)
Winzeler B, Jeanloz N, Nigro N, Suter-Widmer I, Schuetz P, Arici B, Bally M, Blum CA, Bock A, Huber A, Mueller B, Christ-Crain M. Long-term outcome of profound hypo- natremia: a prospective 12 months follow-up study. European Journal of Endocrinology.
2016; 175(6): 499-507 (IF 2015: 3.892)
Sbiti-Rohr D, Kutz A, Christ-Crain M, Thomann R, Zimmerli W, Hoess C, Henzen C, Mueller B, Schuetz P; ProHOSP Study Group. The National Early Warning Score (NEWS) for outcome prediction in emergency department patients with community- acquired pneumonia: results from a 6-year prospective cohort study. BMJ Open. 2016;
6(9): e011021. (IF 2015: 2.562)
Ottiger M, Nickler M, Steuer C, Odermatt J, Huber A, Christ-Crain M, Henzen C, Hoess C, Thomann R, Zimmerli W, Mueller B, Schuetz P. Trimethylamine-N-oxide (TMAO) pre- dicts fatal outcomes in community-acquired pneumonia patients without evident coronary artery disease. European Journal of Internal Medicine. 2016; 36:67-73 (IF 2015: 2.591)
Winzeler B, Lengsfeld S, Nigro N, Suter-Widmer I, Schütz P, Arici B, Bally M, Blum C, Bock A, Huber A, Müller B, Christ-Crain M. Predictors of nonresponse to fluid restriction in hyponatraemia due to the syndrome of inappropriate antidiuresis. Journal of Internal Medicine. 2016; 280(6):609-617 (IF 2015: 7.803)
Graedel L, Merker M, Felder S, Kutz A, Haubitz S, Faessler L, Kaeslin M, Huber A, Mueller B, Schuetz P. Vitamin D Deficiency Strongly Predicts Adverse Medical Outcome Across Different Medical Inpatient Populations: Results From a Prospective Study. Medi- cine (Baltimore). 2016; 95(19): e3533. (IF 2015: 1.206)
Kutz A, Florin J, Hausfater P, Amin D, Amin A, Haubitz S, Conca A, Reutlinger B, Ca- navaggio P, Sauvin G, Bernard M, Huber A, Mueller B, Schuetz P; TRIAGE Study group.
Predictors for Delayed Emergency Department Care in Medical Patients with Acute In- fections - An International Prospective Observational Study. PLoS One. 2016; 11(5):
e0155363. (IF 2015: 3.057)
Aubert V, Bauer M, Bernasconi L, et al. Irreführende Bluttests zur Diagnostik von Nah- rungsmittelunverträglichkeiten. Swiss Medical Forum. 2016; 16(5): 121-122
Huber AR. Heisses Eisen und spezielle Vitamine. der informierte arzt. 2016; 6(8): 9-10
Collinson P, Hammerer-Lercher A, Suvisaari J, Apple FS, Christenson RH, Pulkki K, van Dieijen-Visser MP, Duff CJ, Baum H, Stavljenic-Rukavina A, Aakre KM, Langlois MR, Stankovic S, Laitinen P; Working Group for Cardiac Markers, European Federation of Clini- cal Chemistry and Laboratory Medicine. How Well Do Laboratories Adhere to Recommend- ed Clinical Guidelines for the Management of Myocardial Infarction: The CARdiac MArker Guidelines Uptake in Europe Study (CARMAGUE). Clinical Chemistry. 2016; 62(9): 1264- 71 (IF 2015: 7.457)
Quadri A, Gojanovic B, Noack P, Fuhrer C, Steuer C, Huber A, Kriemler S. Seasonal varia- tion of vitamin D levels in Swiss athletes. Swiss Sports & Exercise Medicine. 2016; 64(1):
19-25
Kutz A, Hausfater P, Amin D, Amin A, Canavaggio P, Sauvin G, Bernard M, Conca A, Hau- bitz S, Struja T, Huber A, Mueller B, Schuetz P; TRIAGE study group. The TRIAGE- ProADM Score for an Early Risk Stratification of Medical Patients in the Emergency De- partment - Development Based on a Multi-National, Prospective, Observational Study.
PLoS One. 2016; 11(12): e0168076 (IF 2015: 3.057)
Strunk D, Weber P, Röthlisberger B, Filges I. Autism and intellectual disability in a patient with two microdeletions in 6q16: a contguous gene deletion syndrome? Molecular Cytoge- netics. 2016; 9: 88 (IF 2015: 1.506)
Randazzo M, Müller A, Carlsson S, Eberli D, Huber A, Grobholz R, Manka L, Mortezavi A, Sulser T, Recker F, Kwiatkowski M. A positive family history as a risk factor for prostate cancer in a population-based study with organised prostate-specific antigen screening: re- sults of the Swiss European Randomised Study of Screening for Prostate Cancer (ERSPC, Aarau). BJU International. 2016; 117(4): 576-83 (IF 2015: 4.387)
Abstracts, Books, Preliminary Communications, Panel Discussions, Posters
Kwiatkowski M, Prause L, Wyler SF, Möltgen T, Huber A, Grobholz R, Manka L, Müller A, Randazzo M, Recker F. Decreasing screening efficacy with increasing age: results from a population-based screening trial – Swiss ERSPC (Aarau). AUA Annual Meeting, San Diego, 2016, 6.-10.5.
Kwiatkowski M, Prause L, Wyler SF, Möltgen T, Huber A, Grobholz R, Manka L, Seifert B, Randazzo M, Recker F. Swiss ProstateCheck: a population based risk-calculator for next- generation prostate cancer screening. AUA Annual Meeting, San Diego, 2016, 6.-10.5.
Kwiatkowski M, Prause L, Wyler SF, Möltgen T, Huber A, Grobholz R, Manka L, Recker F.
Screening for prostate cancer: results from the Swiss section of the ERSPC (Aarau). AUA Annual Meeting, San Diego, 2016, 6.-10.5.
